Pedram et al. found that ERβ activation prevents cardiac fibrosis by blocking the effects of angiotensin II (AngII) and endothelin-1 (ET-1)-induced pro-fibrotic signaling in female mice [39]. This evidence concerns the gene EDN1 and fibrosis.